Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Advances in Drug Discovery

Sally Ward's Biography



Sally Ward, Professor, Texas A&M Health Science Center

Sally Ward completed her Ph.D. research in the Department of Biochemistry, Cambridge University, Cambridge, U.K. in 1985 under the mentorship of Professor David Ellar. From 1985-1988 she was a Research Fellow at Gonville and Caius College whilst working at the Department of Biochemistry, Cambridge University. From 1988 to 1990, she held the Stanley Elmore Senior Research Fellowship at Sidney Sussex College and carried out research in Sir Greg Winter’s laboratory at the MRC Laboratory of Molecular Biology in Cambridge. In 1990 she joined the University of Texas Southwestern Medical Center, Dallas, as an Assistant Professor. From 2002-2014, she was a Professor in the Department of Immunology at the same institution and in 2004 was appointed to the Paul and Betty Meek-FINA Professorship in Molecular Immunology. Since 2014, she has been a Professor at Texas A&M University Health Science Center. Her current research includes the use of a combination of fluorescence imaging, protein engineering and in vivo studies to develop therapeutics to treat cancer and autoimmunity. She is a member of the Board of Distinguished Advisors in the Antibody Society and serves on the editorial boards of mAbs and Protein Engineering, Design and Selection.


Sally Ward Image

Targeting FcRn for therapy: from modulating IgG levels to tumor metabolism

Tuesday, 7 March 2017 at 10:00

Add to Calendar ▼2017-03-06 00:00:002017-03-06 01:00:00Europe/LondonEngineering Antibodies to Modulate their Spatiotemporal BehaviorAdvances in Drug Discovery in Wellcome Genome Campus Conference Centre, Cambridge, UKWellcome Genome Campus Conference Centre, Cambridge, UKSELECTBIOenquiries@selectbiosciences.com

Through its recycling activity, FcRn controls the levels of IgG and albumin in the body. Recent studies involving the modulation of IgG levels for diagnosis and therapy, combined with the identification of FcRn as a metabolic regulator, will be presented.


Add to Calendar ▼2017-03-06 00:00:002017-03-07 00:00:00Europe/LondonAdvances in Drug DiscoveryAdvances in Drug Discovery in Wellcome Genome Campus Conference Centre, Cambridge, UKWellcome Genome Campus Conference Centre, Cambridge, UKSELECTBIOenquiries@selectbiosciences.com